Streetbeat News

Products Services

VTVT

Cantex Pharmaceuticals has received FDA Orphan Drug Designation for azeliragon for the treatment of pancreatic cancer. Azeliragon was originally developed by vtv Therapeutics for Alzheimer's disease and is now licensed to Cantex.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 4:04 pm

PTCT

The European Commission has requested a reevaluation of the negative opinion on PTC Therapeutics' drug Translarna for Duchenne muscular dystrophy, pausing the company's annual revenue guidance. Translarna remains available in Europe, and PTC plans to resubmit its U.S. marketing application in mid-2024.

Portfolio Pulse from Vandana Singh

May 20, 2024 | 4:03 pm

AAPL

ARM

GOOGL

INTC

IYW

MSFT

NVDA

QCOM

XLK

Microsoft is set to unveil new Surface devices featuring Qualcomm chips at an event in Redmond. This marks a shift from Intel processors to Arm-based components. The announcement comes ahead of Microsoft's annual developer conference, highlighting its focus on AI tools. The PC industry faces competition from Apple's Arm-based chips, and Qualcomm's exclusivity on Windows devices ends this year, potentially opening the market to other chipmakers like Nvidia.

Portfolio Pulse from Shivani Kumaresan

May 20, 2024 | 4:03 pm

AVAXUSD

BTCUSD

NVDA

PYTHUSD

VAN

The Bitcoin Fear and Greed Index has turned bullish, indicating a potential rally. Key events include the unlocking of $800M in PYTH supply and $340M in AVAX supply, NVIDIA's Q1 2024 earnings, and VanEck's ETF decision. Bitcoin's price is approaching critical resistance levels, and a strategic trade involving Bitcoin spot, calls, and puts is suggested.

Portfolio Pulse from Murtuza Merchant

May 20, 2024 | 4:01 pm

AFCG

GRWG

HYFM

IIPR

LFLY

NLCP

REFI

SMG

SSIC

UGRO

The article discusses the performance of various cannabis industry subsectors following the HHS announcement on rescheduling. It highlights the stock price movements of ag-tech, cannabis lenders, hemp, and software/media sectors, mentioning specific companies like Scotts Miracle Grow, GrowGeneration, Hydrofarm, Urban Gro, IIPR, NewLake, Chicago Atlantic, AFC Gamma, Silver Spike, and Leafly. The article suggests that while plant-touching stocks have seen significant gains, ancillary sectors like lenders, ag-tech, and software/media offer attractive investment opportunities with less risk.

Portfolio Pulse from Viridian Capital Advisors

May 20, 2024 | 3:51 pm

CIBR

CYBR

IHAK

CyberArk Software Ltd. (NASDAQ:CYBR) has announced its acquisition of Venafi for $1.54 billion, expected to close in the second half of 2024. The deal includes $1 billion in cash and $540 million in shares. Venafi is projected to add $150 million in annual recurring revenue and enhance CyberArk's machine identity solutions, expanding its Total Addressable Market from $50 billion to $60 billion. The acquisition is anticipated to be accretive to margins immediately and offer significant revenue synergies.

Portfolio Pulse from Lekha Gupta

May 20, 2024 | 3:49 pm

NVAX

Novavax announced that the distribution of its R21/Matrix-MTM vaccine across the African region is expected to begin in the coming weeks.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 3:48 pm

AVGO

GOOG

GOOGL

META

MSFT

Broadcom Inc (NASDAQ: AVGO) has launched a new portfolio of 400G PCIe Gen 5.0 Ethernet adapters designed for AI data centers. These adapters aim to address connectivity bottlenecks and offer high performance and low power consumption. The announcement highlights Broadcom's commitment to open standards and collaboration with industry leaders. Tech giants like Microsoft, Meta Platforms, and Alphabet have invested heavily in AI infrastructure, which is expected to benefit Broadcom significantly.

Portfolio Pulse from Anusuya Lahiri

May 20, 2024 | 3:42 pm

DYN

HIMS

MU

OSG

WIX

U.S. stocks saw significant gains on Monday, with notable increases in shares of Overseas Shipholding Group, Hims & Hers Health, Dyne Therapeutics, Wix.com, and others. Key drivers included merger agreements, clinical trial data, and positive financial forecasts.

Portfolio Pulse from Avi Kapoor

May 20, 2024 | 3:37 pm

NCLH

Norwegian Cruise Line Holdings (NCLH) reports a significant increase in interest from Millennial and Gen Z demographics for cruising, as revealed during their Investor Day.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 3:21 pm